posted on 2024-07-31, 14:11authored byWout Callewaert, Bernardo V. Pessanha, Jeroen Lauwaert, David Fernandes del Pozo, Ingmar Nopens, Peter Baldwin, Mairtin McNamara, Joris W. Thybaut
The pharmaceutical industry is under increasing pressure
to reduce
production costs and operate within agile supply chains by leveraging
the capabilities that come with integrated data infrastructures and
increasing access to various forms of modeling. In contrast to bulk
chemical production, pharmaceutical productions typically operate
at significantly lower volumes and allow for narrower variability
in critical parameters due to tightly defined operating ranges. This
makes the data acquired from the process challenging to analyze with
statistical methods, but the application of engineering and scientific
relations as multiscale models offers a more effective way of leveraging
the historical data that are available. In this work, a multiscale
reaction model is developed for an exothermic liquid phase hydrogenation
of a nitrobenzene functionality in the synthesis of an active pharmaceutical
ingredient (API) by using available production data. The developed
model successfully described the interplay between reaction kinetics,
gas–liquid mass transfer, and heat removal present in the process
data, as evident from the simulated versus observed temperature evolution
with batch time, which was used as an indirect measurement of the
reaction conversion. Moreover, the model was also able to reproduce
the temperature profiles in the case of a 30% scale-up. Simulated
concentration profiles indicate that the end of the reaction occurs
within a much shorter time frame than that prescribed by the process
recipe, suggesting that the batch time can be reduced by more than
50%. The results demonstrate the flexibility and predictive power
of this type of modeling approach because this model was developed
using passive data collection of standard process parameters rather
than through a dedicated Design of Experiments (DoE).